Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Elf Labs CEO, David Phillips, speaks to Cheddar about how the company came to be and how it is bringing forth fairytale characters in new and exciting ways.
Don’t panic just yet, but it's starting to look like the economy is slowing down… AKA heading into what one analyst calls a ‘mild form of a recession.’